Pacer Advisors
RGNX icon

Pacer Advisors’s Regenxbio RGNX Stock Holding History

Pacer Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+909
New +$7.54K ﹤0.01% 2340
2024
Q3 		– Sell
-587
Closed -$6.87K – 2671
2024
Q2 		$6.87K Sell
587
-248
-30% -$3.86K ﹤0.01% 3606
2024
Q1 		$17.6K Buy
+835
New +$14.9K ﹤0.01% 3468
2021
Q2 		– Sell
-1,914
Closed -$65K – 1532
2021
Q1 		$65K Buy
1,914
+180
+10% +$7.68K ﹤0.01% 1403
2020
Q4 		$79K Sell
1,734
-612
-26% -$21.4K ﹤0.01% 1383
2020
Q3 		$65K Buy
+2,346
New +$76.5K ﹤0.01% 1294
2018
Q4 		– Sell
-3,011
Closed -$227K – 937
2018
Q3 		$227K Buy
+3,011
New +$217K 0.01% 1006
2018
Q1 		– Sell
-450
Closed -$15K – 1112
2017
Q4 		$15K Buy
+450
New +$13.6K ﹤0.01% 1118

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pacer Advisors's RGNX Position: Q2 2026 in Review

Pacer Advisors opened a new position in Regenxbio (RGNX) in Q2 2026: 909 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2340 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in RGNX as recently as Q2 2024.

Pacer Advisors first reported a position in RGNX in Q4 2017 and has held it in 8 quarters since. The position peaked at $227K in Q3 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Pacer Advisors held 909 shares of Regenxbio worth $11K as of Q2 2026.
  • Regenxbio was a new Pacer Advisors position in Q2 2026.
  • Regenxbio made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2340 holding.
  • Pacer Advisors first reported a position in Regenxbio in Q4 2017 and has held it in 8 quarters since.
  • Pacer Advisors's Regenxbio position peaked at $227K in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.